Chan MY - Search Results

1

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel.

Samman KN, Mehanna P, Takla E, Grenier JC, Chan MY, Lopes RD, Neely ML, Wang TY, Newby LK, Becker RC, Lordkipanidzé M, Ruiz M, Hussin JG, Jolicœur EM. Samman KN, et al. Among authors: chan my. Cell Rep Med. 2021 Jun 4;2(6):100299. doi: 10.1016/j.xcrm.2021.100299. eCollection 2021 Jun 15. Cell Rep Med. 2021. PMID: 34195679 Free PMC article. Clinical Trial.

2

A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor.

Chan MY, Rusconi CP, Alexander JH, Tonkens RM, Harrington RA, Becker RC. Chan MY, et al. J Thromb Haemost. 2008 May;6(5):789-96. doi: 10.1111/j.1538-7836.2008.02932.x. Epub 2008 Feb 18. J Thromb Haemost. 2008. PMID: 18284597 Free article. Clinical Trial.

3

Noninvasive, medical management for non-ST-elevation acute coronary syndromes.

Chan MY, Becker RC, Harrington RA, Peterson ED, Armstrong PW, White H, Fox KA, Ohman EM, Roe MT. Chan MY, et al. Am Heart J. 2008 Mar;155(3):397-407. doi: 10.1016/j.ahj.2007.11.014. Am Heart J. 2008. PMID: 18294472 Review.

4

Identification and treatment of arterial thrombophilia.

Chan MY, Becker RC. Chan MY, et al. Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):3-11. doi: 10.1007/s11936-008-0001-5. Curr Treat Options Cardiovasc Med. 2008. PMID: 18325302

5

Highlights from American Heart Association, November 4-7, 2007, Orlando, Florida, USA. Late-breaking trials summary.

Allen LA, Jolicoeur EM, Melloni C, Lopes RD, Chan MY, Majidi M, Piccini JP, Berger JS, Katz JN, Shah BR. Allen LA, et al. Among authors: chan my. Am Heart J. 2008 Apr;155(4):615-23. doi: 10.1016/j.ahj.2007.12.001. Epub 2008 Feb 13. Am Heart J. 2008. PMID: 18371467 No abstract available.

6

Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.

Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Chan MY, et al. Circulation. 2008 Jun 3;117(22):2865-74. doi: 10.1161/CIRCULATIONAHA.107.745687. Epub 2008 May 27. Circulation. 2008. PMID: 18506005 Clinical Trial.

7

Hypercoagulable states in cardiovascular disease.

Chan MY, Andreotti F, Becker RC. Chan MY, et al. Circulation. 2008 Nov 25;118(22):2286-97. doi: 10.1161/CIRCULATIONAHA.108.778837. Circulation. 2008. PMID: 19029477 Review. No abstract available.

8

Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.

Chan MY, Sun JL, Newby LK, Shaw LK, Lin M, Peterson ED, Califf RM, Kong DF, Roe MT. Chan MY, et al. Circulation. 2009 Jun 23;119(24):3110-7. doi: 10.1161/CIRCULATIONAHA.108.799981. Epub 2009 Jun 8. Circulation. 2009. PMID: 19506116

9

Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.

Chan MY, Weitz JI, Merhi Y, Harrington RA, Becker RC. Chan MY, et al. J Thromb Thrombolysis. 2009 Oct;28(3):366-80. doi: 10.1007/s11239-009-0375-6. J Thromb Thrombolysis. 2009. PMID: 19597766 Review.

10

REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis.

Becker RC, Chan MY. Becker RC, et al. Among authors: chan my. Curr Opin Mol Ther. 2009 Dec;11(6):707-15. Curr Opin Mol Ther. 2009. PMID: 20072947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

620 results

Search Page